🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Vaccine Response

A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age NCT07406360Phase 317 sites📍 Birmingham📍 Walnut Creek📍 Miami GlaxoSmithKline · Tests: MMRVNS, MMRV Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2 NCT06848309n/a1 site📍 St Louis Washington University School of Medicine · Tests: Bronchoscopy Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults NCT06863142Phase 11 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: VRC-FLUMOS0116-00-VP, ALFQ Is a Third Dose of MMRV Vaccine Beneficial for the Adult Population in Alberta? NCT05923970n/a1 site📍 Edmonton University of Alberta · Tests: Serology for antibody levels - Baseline, Serology to assess cell mediated immune (CMI) response - Baseline, Serology fo… Registry of Vaccine Responses in Immune Compromised Patients NCT06463119n/a1 site📍 Geneva Laure Pittet, MD-PhD · Tests: Collection of data in a registry A Study to Evaluate Safety, Reactogenicity, and Immune Response of GVGH iNTS-TCV Vaccine Against Invasive Nontyphoidal Salmonella Disease and Typhoid Fever in Infants NCT07286370Phase 21 site📍 Banjul GlaxoSmithKline · Tests: Low dose of iNTS-TCV, Full dose of iNTS-TCV, TYPHIBEV, Prevenar 13, Nimenrix Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) NCT05672927Phase 41 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site📍 Baltimore University of Maryland, Baltimore · Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE NCT06336317Phase 43 sites📍 Aarhus📍 Örebro📍 Cambridge Region Örebro County · Tests: Influenza vaccine, Placebo Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study NCT05562323n/a3 sites📍 Badalona📍 Barcelona📍 Barcelona Fundación FLS de Lucha Contra el Sida, las Enfermedades Inf… Bone Marrow and Peripheral Blood Immune Responses Study NCT05616546Phase 41 site📍 Atlanta Emory University · Tests: Influenza Vaccine Systems Investigation of Vaccine Responses in Aging and Frailty NCT05291676Phase 21 site📍 New Haven Yale University · Tests: Fluzone, Fluad Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies NCT07534007n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis NCT04588077Phase 41 site📍 Baltimore Mercy Medical Center · Tests: Heplisav-B Injectable Product, 2-dose regimen, Heplisav-B Injectable Product, 3-dose regimen Human Immune Response to Ixodes Scapularis Tick Bites NCT05036707Phase 1, Phase 21 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… · Tests: Xenodiagnosis Ticks, skin biopsy, blood draw Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients NCT02232191Phase 21 site📍 Sacramento University of California, Davis · Tests: Pneumovax-23 A Study to Learn About the Safety and Immune Responses of RSVpreF in Older Adults NCT07819097Phase 315 sites📍 Scottsdale📍 Lake Forest📍 Riverside Pfizer · Tests: RSVpreF, Placebo Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients NCT04948619Phase 21 site📍 Charlotte Wake Forest University Health Sciences · Tests: Vaccine Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk NCT05879965n/a1 site📍 Antwerp Institute of Tropical Medicine, Belgium Study of the Impact of Time of Vaccination on Response to Influenza Vaccine in Patients With Chronic Renal Failure NCT06907667NA1 site📍 Nice Centre Hospitalier Universitaire de Nice · Tests: Vaccine injection Study to Learn About Safety, Tolerability, and Immune Response of a Catch-up Pneumococcal Vaccine in Children and Adolescents NCT07660198Phase 377 sites📍 Birmingham📍 Birmingham📍 Guntersville Pfizer · Tests: PG4, 20-valent pneumococcal conjugate vaccine (20vPnC) Antibiotics and Vaccine Immune Responses Study NCT06148025Phase 41 site📍 Adelaide South Australian Health and Medical Research Institute · Tests: BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule, Neomycin Oral Product, Metoclopramide (Maxolon) Characterizing the Human Airway Immune Response to FluMist Vaccination NCT07177417Phase 41 site📍 St Louis Washington University School of Medicine · Tests: FluMist, inactivated influenza vaccine, bronchoscopy Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC NCT07565740Phase 11 site📍 Chengdu West China Hospital · Tests: WSK-IM05 (4×10^10 vp), WSK-IM05 (8×10^10 vp), WSK-IM05 (1.6x10^11 vp), Tislelizumab Impact Of Kidney Failure On The Regulation Of Humoral Response To Vaccination NCT06635525n/a3 sites📍 Milan📍 Milan📍 Milan Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · Tests: Influenza vaccination, SARS-CoV-2 vaccine A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age NCT06702449Phase 1, Phase 28 sites📍 Lenexa📍 Secaucus📍 Rochester GlaxoSmithKline · Tests: Candidate UTI vaccine low dose formulation 1, Candidate UTI vaccine low dose formulation 2, Candidate UTI vaccine mediu… Shingrix in Renal Transplant Recipients NCT04128189Phase 34 sites📍 Aurora📍 Atlanta📍 Boston University of Colorado, Denver · Tests: Shingrix Using Neoantigen Peptide Vaccine/neoantigen-based DC to Treat Advanced Malignant Solid Tumors NCT05749627NA1 site📍 Nanchang The First Affiliated Hospital of Nanchang University · Tests: Neoantigen peptide vaccine, Neoantigen-based DC immune preparation A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age NCT06806137Phase 36 sites📍 Salvaleón de Higüey📍 Constanza📍 Santo Domingo Oeste GlaxoSmithKline · Tests: Investigational varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine, PCV (pneumococcal conj… Reduced Vaccine Response to HZ/su in SLE NCT07636044n/a1 site📍 Seoul Seoul National University Hospital
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy